Literature DB >> 33577888

Non-coding RNAs: Emerging from the discovery to therapeutic applications.

B Baptista1, M Riscado1, J A Queiroz1, C Pichon2, F Sousa3.   

Abstract

The knowledge about non-coding RNAs (ncRNAs) is rapidly increasing with new data continuously emerging, regarding their diverse types, applications, and roles. Particular attention has been given to ncRNA with regulatory functions, which may have a critical role both in biological and pathological conditions. As a result of the diversity of ncRNAs and their ubiquitous involvement in several biologic processes, ncRNA started to be considered in the biomedical field, with immense potential to be exploited either as biomarkers or as therapeutic agents in certain pathologies. Indeed, ncRNA-based therapeutics have been proposed in many disorders and some even reached clinical trials. However, to prepare an RNA product suitable for pharmacological applications, certain criteria must be fulfilled, and it has to be guaranteed RNA purity, stability, and bioactivity. So, in this review, the different types of ncRNAs are identified and characterized, by describing their biogenesis, functions, and applications. A perspective on the main challenges and innovative approaches for the future and broad therapeutic application of RNA is also presented.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biological activity; Diagnosis; Therapeutic application; ncRNA

Year:  2021        PMID: 33577888     DOI: 10.1016/j.bcp.2021.114469

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Whole-transcriptome sequencing identifies key mRNAs, miRNAs, lncRNAs, and circRNAs associated with unexplained recurrent pregnancy loss.

Authors:  Yan Wang; Qing Cheng; Zhengyi Xia; Ran Zhou; Yiming Li; Lulu Meng; Qing Xu; Jianxin Tan; Zhengfeng Xu
Journal:  Cell Tissue Res       Date:  2022-05-07       Impact factor: 5.249

2.  RNA therapeutics: From biochemical pharmacology to technology development and clinical applications.

Authors:  Baitang Ning; Ai-Ming Yu
Journal:  Biochem Pharmacol       Date:  2021-04-16       Impact factor: 6.100

Review 3.  Non-Coding RNAs Regulate Placental Trophoblast Function and Participate in Recurrent Abortion.

Authors:  Xin Chen; Duan-Ying Guo; Tai-Lang Yin; Jing Yang
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

4.  What is beyond LncRNAs in breast cancer: A special focus on colon cancer-associated Transcript-1 (CCAT-1).

Authors:  Noha A Selem; Rana A Youness; Mohamed Z Gad
Journal:  Noncoding RNA Res       Date:  2021-12-01

Review 5.  Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination.

Authors:  Ai-Ming Yu; Mei-Juan Tu
Journal:  Pharmacol Ther       Date:  2021-08-14       Impact factor: 13.400

Review 6.  Noncoding RNAs Emerging as Drugs or Drug Targets: Their Chemical Modification, Bio-Conjugation and Intracellular Regulation.

Authors:  Jin Wang; Tian Tian; Xin Li; Yan Zhang
Journal:  Molecules       Date:  2022-10-09       Impact factor: 4.927

Review 7.  mRNA, a Revolution in Biomedicine.

Authors:  Bruno Baptista; Rita Carapito; Nabila Laroui; Chantal Pichon; Fani Sousa
Journal:  Pharmaceutics       Date:  2021-12-05       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.